The Uromigos Episode 37: Regoratinib (FGFR inhibitor) and Atezolizumab in UC With Jonathan Rosenberg

The Uromigos and Dr. Jonathan Rosenberg, medical oncologist at Memorial Sloan Kettering Cancer Center, discuss everything you wanted to know about FGFR inhibition but were afraid to ask.